Press Release

Oncology Nutrition Market to Grow with a CAGR of 8.41% through 2028

Increasing incidence of cancer and the recognition of nutritional challenges in cancer patients are expected to drive the Global Oncology Nutrition Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Oncology Nutrition Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Oncology Nutrition Market stood at USD 2.14 billion in 2022 and is anticipated to grow with a CAGR of 8.41% in the forecast period, 2024-2028. This can be attributed to global outreach. The global oncology nutrition market transcends geographical boundaries. Cancer is a worldwide health concern, affecting individuals in both developed and developing countries. As awareness of the importance of proper nutrition in cancer care grows, the market's reach expands, creating opportunities for growth and development in various regions.

Furthermore, collaboration between nutritionists, oncologists, researchers, and the food industry is expected to increase. This interdisciplinary approach will lead to more evidence-based nutritional interventions and the development of innovative products that meet the specific needs of cancer patients.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Oncology Nutrition Market.”

 

The onset of the COVID-19 pandemic brought the oncology nutrition market into focus, despite significant disruptions to healthcare systems. For example, a study published in May 2021 by Nutrition and Cancer concentrated on establishing nutritional guidelines to manage and prevent complications in all cancer patients during the COVID-19 pandemic. Cancer patients are particularly vulnerable to illnesses due to weakened immune systems or the effects of anticancer treatments. Additionally, an article published by the National Library of Medicine in June 2021 highlighted the role of nutrition, vitamin and mineral supplementation, and the microbiota in various phases of COVID-19, as well as the significance of diet in susceptibility, prevention, and management of COVID-19 among cancer patients. This underscored the need for comprehensive nutritional guidance for all cancer patients during the pandemic. As COVID-19 cases decreased, the market gradually stabilized, and demand for oncology nutrition returned to normal levels, indicating the pandemic's substantial impact on the market during the forecast period.

The primary drivers behind the growth of the oncology nutrition market include the increasing global prevalence of cancer and the introduction of novel oncology nutrition products. According to an article by BioMed Central Ltd in April 2022, Germany is expected to witness a 20% increase in new cancer cases by 2030. Furthermore, as stated in the AACR Cancer Progress Report 2022, the number of cancer survivors in the United States grew by over a million in the past three years, reaching more than 18 million as of January 1, 2022. The utilization of nutritional products during and after cancer treatment provides the body with the ability to combat the disease and offers resilience against the side effects of treatment, thereby driving market growth.

Additionally, government and private agencies play a pivotal role in raising awareness and contributing to market growth. For instance, the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net recommends a healthy diet, rich in fruits, vegetables, and whole grains, after cancer treatment is completed. Moreover, the Agency for Healthcare Research and Quality reported a high prevalence of malnutrition among adult cancer patients in October 2021, with estimates ranging from 25% to 80% across different patient populations. This increase in malnutrition among cancer patients is expected to fuel demand for oncology nutrition, further boosting market growth over the forecast period.

The Global Oncology Nutrition Market is segmented into cancer type, nutrition, formula, distribution channel, end user, regional distribution, and company.

Based on its cancer type, the lung cancer segment is expected to experience growth throughout the study period due to several factors. These include the global high prevalence of lung cancer, an increase in the use of nutritional supplements for lung cancer patients, and a growing awareness of the importance of incorporating nutritional supplements into one's diet. For example, according to the Lung Cancer Fact 2022 report, lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States alone, it was estimated that 236,740 individuals would be diagnosed with lung cancer in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer patients, there is a growing recognition of the vital role nutrition plays in bolstering the body's ability to combat disease and in providing the necessary strength and stamina to endure the side effects of treatment. As a result, the demand for oncology nutrition is expected to increase over the forecasted period.

Based on region, North America is anticipated to experience growth in the overall oncology nutrition market throughout the projected period. This can be attributed to various factors, including the increasing prevalence of cancer and the presence of advanced healthcare infrastructure, among other significant drivers. For instance, the American Cancer Society's 2022 report estimates approximately 1.9 million new cancer cases in the United States for the same year. Additionally, initiatives by government bodies, new product launches, and collaborations related to cancer nutrition supplements are contributing to market expansion. For example, the "2022 Oncology Nutrition Symposium" conducted by the Academy of Nutrition and Dietetics on June 20, 2022, addressed various aspects of oncology nutrition, encompassing research, prevention, treatment, recovery, palliative care, and hospice.

 

Major companies operating in Global Oncology Nutrition Market are:

  • Abbott Laboratories Inc
  • Nestle SA
  • Fresenius Kabi AG
  • B Braun SE
  • Hormel Foods Corporation
  • Danone SA
  • MEIJI Holdings Co Ltd
  • Global Health Products, Inc.
  • Victus Inc
  • Mead Johnson & Co LLC

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global oncology nutrition market is poised for significant growth and transformation, with emerging trends focusing on personalization, nutrigenomics, digital health solutions, functional foods, cancer prevention, sustainability, global accessibility, and collaborative research efforts. The upcoming trends underscore the importance of nutrition in cancer care and highlight the industry's commitment to improving the quality of life and outcomes for individuals battling cancer. As these trends continue to evolve, they promise to shape the future of oncology nutrition, offering hope and support to cancer patients worldwide,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Oncology Nutrition Market By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By Formula (Standard Formula, Elemental Formula, Specialized Formula), By Formula (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Oncology Nutrition Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Oncology Nutrition Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com

Relevant News